These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4053042)

  • 1. High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: improved method for the synthesis of diethylenetriaminepentaacetic acid conjugates.
    Paxton RJ; Jakowatz JG; Beatty JD; Beatty BG; Vlahos WG; Williams LE; Clark BR; Shively JE
    Cancer Res; 1985 Nov; 45(11 Pt 2):5694-9. PubMed ID: 4053042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: biodistribution and imaging in nude mice bearing human colon cancer xenografts.
    Jakowatz JG; Beatty BG; Vlahos WG; Porudominsky D; Philben VJ; Williams LE; Paxton RJ; Shively JE; Beatty JD
    Cancer Res; 1985 Nov; 45(11 Pt 2):5700-6. PubMed ID: 4053043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of decreasing liver uptake of 111In-labeled anti-carcinoembryonic antigen monoclonal antibody by specific antibody pretreatment in tumor bearing mice.
    Beatty BG; O'Conner-Tressel M; Do T; Paxton RJ; Beatty JD
    Cancer Res; 1990 Feb; 50(3 Suppl):846s-851s. PubMed ID: 2297732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of indium-111 in the liver of mice following administration of indium-111-DTPA-labeled monoclonal antibodies: influence of labeling parameters, physiologic parameters, and antibody dose.
    Schuhmacher J; Klivényi G; Matys R; Kirchgebner H; Hauser H; Maier-Borst W; Matzku S
    J Nucl Med; 1990 Jun; 31(6):1084-93. PubMed ID: 2348237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody.
    Kobayashi H; Wu C; Kim MK; Paik CH; Carrasquillo JA; Brechbiel MW
    Bioconjug Chem; 1999; 10(1):103-11. PubMed ID: 9893971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of radionuclides to pretargeted monoclonal antibodies using dihydrofolate reductase and methotrexate in an affinity system.
    Hawkins GA; McCabe RP; Kim CH; Subramanian R; Bredehorst R; McCullers GA; Vogel CW; Hanna MG; Pomato N
    Cancer Res; 1993 May; 53(10 Suppl):2368-73. PubMed ID: 8485723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretargeting of carcinoembryonic antigen-expressing tumors with a biologically produced bispecific anticarcinoembryonic antigen x anti-indium-labeled diethylenetriaminepentaacetic acid antibody.
    van Schaijk FG; Oosterwijk E; Soede AC; Broekema M; Frielink C; McBride WJ; Goldenberg DM; Corstens FH; Boerman OC
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7130s-7136s. PubMed ID: 16203812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and testing of a binary catalytic system for imaging of signal amplification in vivo.
    Bogdanov A; Kang HW; Querol M; Pretorius PH; Yudina A
    Bioconjug Chem; 2007; 18(4):1123-30. PubMed ID: 17508710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of metabolites of 111In-diethylenetriaminepentaacetic acid-monoclonal antibodies and antibody fragments in vivo.
    Rogers BE; Franano FN; Duncan JR; Edwards WB; Anderson CJ; Connett JM; Welch MJ
    Cancer Res; 1995 Dec; 55(23 Suppl):5714s-5720s. PubMed ID: 7493333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative reactivity of DTPA, immunoreactive antibody-DTPA conjugates, and nonimmunoreactive antibody-DTPA conjugates toward indium-111.
    Paik CH; Hong JJ; Ebbert MA; Heald SC; Reba RC; Eckelman WC
    J Nucl Med; 1985 May; 26(5):482-7. PubMed ID: 3989604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A facile, water-soluble method for modification of proteins with DOTA. Use of elevated temperature and optimized pH to achieve high specific activity and high chelate stability in radiolabeled immunoconjugates.
    Lewis MR; Raubitschek A; Shively JE
    Bioconjug Chem; 1994; 5(6):565-76. PubMed ID: 7873659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of indium chelates attached to monoclonal antibody: minimal transchelation of indium from benzyl-EDTA chelate in vivo.
    Deshpande SV; Subramanian R; McCall MJ; DeNardo SJ; DeNardo GL; Meares CF
    J Nucl Med; 1990 Feb; 31(2):218-24. PubMed ID: 2107283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake and metabolism of 111In-labeled monoclonal antibody B6.2 by the rat liver.
    Jones PL; Brown BA; Sands H
    Cancer Res; 1990 Feb; 50(3 Suppl):852s-856s. PubMed ID: 2297733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
    Brouwers AH; van Eerd JE; Frielink C; Oosterwijk E; Oyen WJ; Corstens FH; Boerman OC
    J Nucl Med; 2004 Feb; 45(2):327-37. PubMed ID: 14960657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Reagent development.
    Karacay H; Sharkey RM; Govindan SV; McBride WJ; Goldenberg DM; Hansen HJ; Griffiths GL
    Bioconjug Chem; 1997; 8(4):585-94. PubMed ID: 9258459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing DTPA conjugation with antibodies by cyclic DTPA anhydride.
    Paik CH; Ebbert MA; Murphy PR; Lassman CR; Reba RC; Eckelman WC; Pak KY; Powe J; Steplewski Z; Koprowski H
    J Nucl Med; 1983 Dec; 24(12):1158-63. PubMed ID: 6644376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Labeling of monoclonal antibodies with samarium-153 for combined radioimmunoscintigraphy and radioimmunotherapy.
    Boniface GR; Izard ME; Walker KZ; McKay DR; Sorby PJ; Turner JH; Morris JG
    J Nucl Med; 1989 May; 30(5):683-91. PubMed ID: 2785586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of new heterobifunctional reagent for radiometallic labeling of antibodies.
    Wang TS; Ng AK; Alsedairy S; Fawwaz RA; Hardy MA; Alderson PO
    NCI Monogr; 1987; (3):145-8. PubMed ID: 3821912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reassessment of diethylenetriaminepentaacetic acid (DTPA) as a chelating agent for indium-111 labeling of polypeptides using a newly synthesized monoreactive DTPA derivative.
    Arano Y; Uezono T; Akizawa H; Ono M; Wakisaka K; Nakayama M; Sakahara H; Konishi J; Yokoyama A
    J Med Chem; 1996 Aug; 39(18):3451-60. PubMed ID: 8784442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies.
    Wong JYC ; Chu DZ; Yamauchi DM; Williams LE; Liu A; Wilczynski S; Wu AM; Shively JE; Doroshow JH; Raubitschek AA
    Clin Cancer Res; 2000 Oct; 6(10):3855-63. PubMed ID: 11051230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.